Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
Department of Health and Human Services
Description
The NIH Blueprint for Neuroscience Research is planning to release a funding opportunity for projects aimed at developing innovative medical devices for preventing, monitoring, diagnosing, and treating nervous or neuromuscular disorders. The program, called Blueprint MedTech, seeks to accelerate the translation of new technologies from early development to clinical studies by offering non-dilutive funding and additional support services. While applications are not yet being accepted, this no…
The purpose of this announcement is to encourage investigators to pursue translational activities and clinical feasibility studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this progr…
Source
Grant ID
PAR-25-383
Agency
Department of Health and Human Services
Subcategory/Subagency
National Institutes of Health
Eligibility
The following categories of applicants are invited to apply:
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- State governments
- Native American tribal governments (Federally recognized)
- County governments
- Independent school districts
- Small businesses
- For profit organizations other than small businesses
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
Links
Similar opportunities
- Small Business Translator: MedTech and Digital Health Technologies
Department of Health and Human Services
- Development and Validation of Animal Models and Ex Vivo Systems for Neurological and Neuromuscular Disorders
National Institutes of Health
- BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required)
Department of Health and Human Services
- Early Stage Clinical Trials for Novel Mechanism of Action Drugs or Devices for Psychiatric Disorders
National Institutes of Health
- Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
Department of Health and Human Services